Tarrex Biopharma is aprivately funded drug development company with offices in San Diego, California and in Xiamen, China.  Tarrex is developing novel molecular targeted cancer therapeutics through in-licensing or collaborations with universities, research institutions or other small biotech firms.  We focus on early stage programs with global intellectual property rights and develop into valuable clinical assets for out-licensing.